Journal: iScience

Article Title: MCM7 supports the stemness of bladder cancer stem-like cells by enhancing autophagic flux

doi: 10.1016/j.isci.2022.105029

Figure Lengend Snippet:

Article Snippet: LIF , MedChemExpress , Cat. # HY-P73276.

Techniques: Recombinant, MTS Assay, Protein Concentration, Software

Journal: Breast cancer research : BCR

Article Title: PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR.

doi: 10.1186/s13058-024-01791-z

Figure Lengend Snippet: Fig. 4 PTHrP differentially regulates p27 through LIFR in breast cancer cells. (A) Immunofluorescence staining and quantification of LIFR in primary tumors from mice inoculated with MSCV, FLSEC, DNLS, or DNLS + CTERM cells. All panels = 40X and scale bars = 50 μm. (B) Western blot analysis of p27, pERK, ERK, p-p38, p38 and tubulin (loading control) protein levels in MSCV, FLSEC, DNLS, or DNLS + CTERM cells treated with vehicle (DMSO) or LIFR inhibitor (EC359, 50nM or 100nM) for 24 h. Densitometry for western blot analysis of (C) p27, (D) pERK/ERK and (E) p-p38/p38 described in (B). (A) **p < 0.01 vs. DNLS by unpaired t-test. (C) *p < 0.05 vs. DNLS by unpaired t-test or *p < 0.05 vs. MSCV by one-way ANOVA with multiple comparisons. (D & E) *p < 0.05 vs. MSCV by one-way ANOVA with multiple comparisons or *p < 0.05, **p < 0.01, ***p < 0.001 versus vehicle by two-way ANOVA. Graphs represent mean ± SEM

Article Snippet: The following day, cells were treated with EC359, a leukemia inhibitory factor receptor (LIFR) inhibitor (50nM or 100nM; MedChemExpress; Catalog No. HY-1,201,420) or vehicle (0.1% dimethyl sulfoxide, DMSO) for 1, 6, or 24 h in full-serum media.

Techniques: Immunofluorescence, Staining, Western Blot, Control

Journal: Breast cancer research : BCR

Article Title: PTHrP intracrine actions divergently influence breast cancer growth through p27 and LIFR.

doi: 10.1186/s13058-024-01791-z

Figure Lengend Snippet: Fig. 6 Model of PTHrP domain-specific actions in breast cancer progression and bone colonization. In the primary breast site (top left panel, left of ar rows), PTHrP lacking the NLS and C-terminal domain decreases tumor cell proliferation through p27 induction driven by the tumor suppressor leukemia inhibitory factor receptor (LIFR). PTHrP lacking the NLS and C-terminal domain also preferentially induces p38 phosphorylation and signaling to inhibit cell cycling downstream of LIFR activation. In the breast, truncated PTHrP lacking the NLS alone (top left panel, right of arrows) downregulates LIFR expression (denoted by transparent coloring) and prevents induction of p27 expression and activation of p38 signaling (denoted by dashed arrows, dot ted outlines and transparent coloring) to drive cell proliferation and tumor growth. In bone disseminated tumor cells (bottom panel), LIFR expression is downregulated and the induction of p27 by PTHrP lacking the NLS and C-terminal domain persists, but is not sufficient to repress metastatic outgrowth (denoted by dashed inhibitor line), in contrast to the primary tumor. In the bone, tumor cells expressing PTHrP peptides lacking the NLS or NLS and C- terminal domain readily proliferate into metastatic tumors. Image created with Biorender.com

Article Snippet: The following day, cells were treated with EC359, a leukemia inhibitory factor receptor (LIFR) inhibitor (50nM or 100nM; MedChemExpress; Catalog No. HY-1,201,420) or vehicle (0.1% dimethyl sulfoxide, DMSO) for 1, 6, or 24 h in full-serum media.

Techniques: Phospho-proteomics, Activation Assay, Expressing

Journal: Reproductive Biology and Endocrinology : RB&E

Article Title: Expressions of candidate molecules in the human fallopian tube and chorionic villi of tubal pregnancy exposed to levonorgestrel emergency contraception

doi: 10.1186/1477-7827-11-46

Figure Lengend Snippet: Antibody used for immunohistochemistry

Article Snippet: LIF , Boster, Wuhan, China , 1:100 , Rabbit monoclonal , citrate buffer , microwave heating on high for 20 minutes.

Techniques: Concentration Assay